Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CardioTech (CTE) - Arificial Artery Replacements -- Ignore unavailable to you. Want to Upgrade?

To: Riley G who wrote (51)	4/12/1998 2:14:00 PM
From: rag2rag	Read Replies (1) \| Respond to of 57

regards, Is this information different from the S13G filing and the F-3 filing that EDGAR on-line sent me - the filing mentioned 832,080 common stock. I did not see the dollar figures. Th S13-G mentions 10 % common stock held by the director and the F-3 mentions 16.3 % held by the Limited Partnership. IMHO, if these are separate filings, then 36 % of CTEownership is now in the hands of this new group. The filing dates are 4/10/98. freeedgar.com freeedgar.com Pardon my ignorance and I welcome any corrections. I don't want to make an erroneous assumption. Any experts out there ? is there a simpler way to understand change of ownership ? LOST in SEC filings, long CTE jag-dish